日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation

台湾肿瘤消融学会制定的转移性肝肿瘤消融共识指南

Wu, Ming Shun; Kao, Wei-Yu; Chiang, Ming-Feng; Chuang, Po-Heng; Hsu, Shih-Jer; Wang, Shen-Yung; Chang, Ching-Wei; Lin, Chen-Chun; Hung, Chao-Hung; Wu, Chih Horng; Chen, San-Chi; Lee, Hsin-Lun; Hwang, Jen-I; Liang, Po-Chin; Lin, Shi-Ming; Wang, Chia-Chi

Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab

非甲状腺疾病综合征预示着接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者预后不良

Chen, I-Wen; Lin, Cheng-Wei; Lin, Po-Ting; Teng, Wei; Su, Chung-Wei; Wu, Tsung-Han; Hsieh, Yi-Chung; Chen, Wei-Ting; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen

Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis

预后营养指数预测接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者的预后:一项倾向评分匹配分析

Kuo, Yuan-Hung; Teng, Wei; Chen, Yen-Hao; Lin, Po-Ting; Wu, Tsung-Han; Su, Chung-Wei; Chen, Wei-Ting; Lin, Chen-Chun; Hung, Chao-Hung; Lu, Sheng-Nan; Lin, Shi-Ming; Wang, Jing-Houng; Lin, Chun-Yen

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

度伐利尤单抗联合或不联合贝伐珠单抗治疗肝细胞癌经动脉化疗栓塞术(EMERALD-1):一项多区域、随机、双盲、安慰剂对照的3期研究

Sangro, Bruno; Kudo, Masatoshi; Erinjeri, Joseph P; Qin, Shukui; Ren, Zhenggang; Chan, Stephen L; Arai, Yasuaki; Heo, Jeong; Mai, Anh; Escobar, Jose; Lopez Chuken, Yamil Alonso; Yoon, Jung-Hwan; Tak, Won Young; Breder, Valeriy V; Suttichaimongkol, Tanita; Bouattour, Mohamed; Lin, Shi-Ming; Peron, Jean-Marie; Nguyen, Quang T; Yan, Lunan; Chiu, Chang-Fang; Santos, Florinda A; Veluvolu, Anil; Thungappa, Satheesh Chiradoni; Matos, Marco; Żotkiewicz, Magdalena; Udoye, Stephanie I; Kurland, John F; Cohen, Gordon J; Lencioni, Riccardo

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma

台湾肝癌协会中期肝细胞癌管理共识指南

Lee, I-Cheng; Wang, Hung-Wei; Teng, Wei; Lin, Tsung-Jung; Chen, Chien-Hung; Lai, Hsueh-Chou; Lee, Teng-Yu; Chang, Ching-Wei; Hung, Chao-Hung; Dai, Chia-Yen; Hung, Yi-Ping; Shen, Ying-Chun; Su, Chien-Wei; Ho, Ming-Chih; Lee, Wei-Chen; Chau, Gar-Yang; Ting, Chin-Tsung; Liang, Po-Chin; Liu, Chien-An; Chang, Pi-Yi; Chen, Kuan-Yang; Lin, Shi-Ming; Chen, Li-Tzong; Huang, Yi-Hsiang

Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study

瑞戈非尼治疗肝细胞癌的真实世界实践(REFINE):一项前瞻性观察研究

Kim, Yoon Jun; Merle, Philippe; Finn, Richard S; Kudo, Masatoshi; Klümpen, Heinz-Josef; Lim, Ho Yeong; Ikeda, Masafumi; Granito, Alessandro; Masi, Gianluca; Gerolami, René; Cho, Sung Bum; Hsu, Chih-Hung; Huang, Yi-Hsiang; Jeng, Long-Bin; Kim, Do Young; Lin, Shi-Ming; Pinter, Matthias; Shao, Guoliang; Kato, Naoya; Kurosaki, Masayuki; Numata, Kazushi; Kuo, Kung-Kai; Mao, Yilei; Lin, Yih-Jyh; Zhu, Kangshun; Twumasi-Ankrah, Philip; Khan, Javeed; Awan, Maria; Ozgurdal, Kirhan; Qin, Shukui

Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma

亚洲肝细胞癌肿瘤消融指南会议

Shiina, Shuichiro; Tateishi, Ryosuke; Choi, Joon Il; Kim, So Yeon; Meng, Zhiqiang; Shen, Lujun; Lu, Sheng-Nan; Hwang, Jen-I; Tobari, Maki; Maruyama, Hitoshi; Batsaikhan, Terguunbileg; Deng, Qing; Canseco, Lariza Marie; Asaoka, Yoshinari; Lin, Shi-Ming; Huang, Kai-Wen; Rhim, Hyunchul; Liang, Ping; Pua, Uei; Tanaka, Masatoshi; Wu, Peihong

Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)

外泌体非编码RNA在癌症相关成纤维细胞介导的治疗耐药性中的作用(综述)

Li, Junxin; Huang, Yu; Fu, Lin; Shi, Ming; Hu, Gongli; Du, Fei; Wang, Zhongshu; Xiao, Yi; Zhang, Yan; Li, Yanyu

Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab

中度免疫相关性肝损伤是接受阿特珠单抗联合贝伐珠单抗治疗的肝癌患者的良好预后因素

Wu, Tai-Chi; Lin, Po-Ting; Teng, Wei; Shen, Eric Yi-Liang; Su, Chung-Wei; Hsieh, Yi-Chung; Chen, Wei-Ting; Wu, Tsung-Han; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen

Hepatocellular carcinoma systemic treatment update: From early to advanced stage

肝细胞癌全身治疗进展:从早期到晚期

Teng, Wei; Wu, Tai-Chi; Lin, Shi-Ming